Skip to content

13F-HR filed by M28 Capital Management LP

M28 Capital Management LP filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-11, with 12 holding rows worth $75,677,508.

Accession
0000902664-23-004379
Filed
2023-08-11
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2023

A holdings report, 12 entries on the cover page, a total value of $75,677,508 stated on the cover page (in dollars after the unit check, H1), rows summing to $75,677,508 with VALUE read as dollars as filed, 13F file number 028-21846. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
WAVE LIFE SCIENCES LTD SHSY95308105Stock7,050,000$25,662,000dollars as filed
ROCKET PHARMACEUTICALS INC77313F106COM630,380$12,525,651dollars as filed
INVIVYD INC00534A102COMMON STOCK9,248,250$9,710,663dollars as filed
SPRINGWORKS THERAPEUTICS INC85205L107COM197,700$5,183,694dollars as filed
CURIS INC231269200COM6,000,000$4,980,000dollars as filed
STOKE THERAPEUTICS INC86150R107COM346,190$3,680,000dollars as filed
TG THERAPEUTICS INC COM88322Q108Stock142,500$3,539,700dollars as filed
PROQR THERAPEUTICS NVN71542109SHS EURO1,910,600$3,095,172dollars as filed
BRIDGEBIO PHARMA INC10806X102COM166,200$2,858,640dollars as filed
ARROWHEAD PHARMACEUTICALS IN04280A100COM67,400$2,403,484dollars as filed
SILENCE THERAPEUTICS PLC82686Q101ADS363,800$2,000,900dollars as filed
NEXIMMUNE INC65344D109COM133,442$37,604dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000902664-23-004379this filing2023-08-11acceptance time not in the bulk data set